1. Home
  2. CRDF vs PODC Comparison

CRDF vs PODC Comparison

Compare CRDF & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

SELL

Current Price

$0.87

Market Cap

67.1M

Sector

Health Care

ML Signal

SELL

Logo PodcastOne Inc.

PODC

PodcastOne Inc.

SELL

Current Price

$1.84

Market Cap

65.6M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
CRDF
PODC
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.1M
65.6M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
CRDF
PODC
Price
$0.87
$1.84
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$5.14
★ $5.67
AVG Volume (30 Days)
★ 1.0M
307.8K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 27.37
N/A
EPS
N/A
★ N/A
Revenue
★ $365,993.00
N/A
Revenue This Year
N/A
$12.43
Revenue Next Year
N/A
$18.97
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 49.61
N/A
52 Week Low
$0.71
$1.41
52 Week High
$3.31
$5.20

Technical Indicators

Market Signals
Indicator
CRDF
PODC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CRDF
PODC

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more. It generates all its revenue from United States. PodcastOne has built a distribution network reaching over a billion monthly impressions across all channels, including YouTube, Spotify, Apple Podcasts, and iHeartRadio.

Share on Social Networks: